Barriers and facilitators to implementing dementia care mapping in care homes: results from the DCM™ EPIC trial process evaluation.


Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
08 02 2019
Historique:
received: 13 07 2018
accepted: 23 01 2019
entrez: 10 2 2019
pubmed: 10 2 2019
medline: 29 1 2020
Statut: epublish

Résumé

Psychosocial person-centred interventions are considered best practice for addressing complex behaviours and care needs such as agitation and anxiety, and for improving the quality of life of people with dementia in care homes. Dementia Care Mapping (DCM™) is an established practice development tool and process aimed to help care home staff deliver more person-centred care. To date, few studies have evaluated the efficacy of DCM™ and have found mixed results. These results are suggested to be the outcome of intervention implementation, which may be impacted by a range of factors. This study reports the barriers and facilitators to DCM™ implementation in care homes found during the process evaluation conducted as part of a randomized controlled trial. Eighteen of the 31 DCM™ intervention care homes were recruited to participate in the embedded process evaluation. Semi-structured interviews were conducted with 83 participants, comprising care home managers, trained DCM™ users (mappers), expert external mappers, staff members, relatives, and residents. Barriers and facilitators to DCM™ implementation were found at the mapper level (e.g. motivation and confidence), the DCM™ intervention level (e.g. understanding of DCM™) and the care home level (e.g. staffing issues, manager support). Further barriers caused by the burden of trial participation were also identified (e.g. additional paperwork). Implementing DCM™ is complex and a greater consideration of potential barriers and facilitators in planning future studies and in practice could help improve implementation. Current Controlled Trials ISRCTN82288852 , registered 16/01/2014.

Sections du résumé

BACKGROUND
Psychosocial person-centred interventions are considered best practice for addressing complex behaviours and care needs such as agitation and anxiety, and for improving the quality of life of people with dementia in care homes. Dementia Care Mapping (DCM™) is an established practice development tool and process aimed to help care home staff deliver more person-centred care. To date, few studies have evaluated the efficacy of DCM™ and have found mixed results. These results are suggested to be the outcome of intervention implementation, which may be impacted by a range of factors. This study reports the barriers and facilitators to DCM™ implementation in care homes found during the process evaluation conducted as part of a randomized controlled trial.
METHODS
Eighteen of the 31 DCM™ intervention care homes were recruited to participate in the embedded process evaluation. Semi-structured interviews were conducted with 83 participants, comprising care home managers, trained DCM™ users (mappers), expert external mappers, staff members, relatives, and residents.
RESULTS
Barriers and facilitators to DCM™ implementation were found at the mapper level (e.g. motivation and confidence), the DCM™ intervention level (e.g. understanding of DCM™) and the care home level (e.g. staffing issues, manager support). Further barriers caused by the burden of trial participation were also identified (e.g. additional paperwork).
CONCLUSIONS
Implementing DCM™ is complex and a greater consideration of potential barriers and facilitators in planning future studies and in practice could help improve implementation.
TRIAL REGISTRATION
Current Controlled Trials ISRCTN82288852 , registered 16/01/2014.

Identifiants

pubmed: 30736748
doi: 10.1186/s12877-019-1045-y
pii: 10.1186/s12877-019-1045-y
pmc: PMC6368774
doi:

Banques de données

ISRCTN
['ISRCTN82288852']

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

37

Subventions

Organisme : Department of Health
ID : 11/15/13
Pays : United Kingdom

Références

Lancet Neurol. 2009 Apr;8(4):317-25
pubmed: 19282246
J Clin Nurs. 2017 Mar;26(5-6):751-765
pubmed: 27534732
PLoS One. 2013 Jul 02;8(7):e67325
pubmed: 23844003
BMJ. 2006 Feb 18;332(7538):413-6
pubmed: 16484270
Clin Interv Aging. 2018 Jan 26;13:165-177
pubmed: 29416325
Nurse Res. 2011;18(2):52-62
pubmed: 21319484
Int Psychogeriatr. 2013 Nov;25(11):1849-58
pubmed: 23924580
Int Psychogeriatr. 2017 Oct;29(10):1609-1618
pubmed: 28629482
Tijdschr Gerontol Geriatr. 2009 Jun;40(3):102-12
pubmed: 19731747
Dement Geriatr Cogn Disord. 2013;36(5-6):340-53
pubmed: 24022375
Int Psychogeriatr. 2015 Nov;27(11):1875-92
pubmed: 26138674
Aging Ment Health. 2007 May;11(3):237-45
pubmed: 17558574
Int J Geriatr Psychiatry. 2014 Aug;29(8):797-807
pubmed: 24535885
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Trials. 2016 Jun 24;17(1):300
pubmed: 27341812

Auteurs

Alys W Griffiths (AW)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, LS1 3HE, UK. alys.griffiths@leedsbeckett.ac.uk.

Rachael Kelley (R)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, LS1 3HE, UK.

Lucy Garrod (L)

Oxford Health NHS Foundation Trust, Oxford, UK.

Devon Perfect (D)

Oxford Health NHS Foundation Trust, Oxford, UK.

Olivia Robinson (O)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, LS1 3HE, UK.

Emily Shoesmith (E)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, LS1 3HE, UK.

Joanne McDermid (J)

Wolfson Centre for Aged Related Diseases, King's College London, London, UK.

Natasha Burnley (N)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, LS1 3HE, UK.

Claire A Surr (CA)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, LS1 3HE, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH